About Us

 

Nami wave image

Our Story


From Glasgow Lab to Global Impact

Nami Surgical was founded in 2021 by Dr Nico Fenu and Dr Rebecca Cleary, researchers at the University of Glasgow’s Centre for Medical and Industrial Ultrasonics. Built on Dr Fenu’s PhD research, the company was founded on a clear clinical gap that no robotic platform today offers integrated articulated ultrasonic advanced energy. Nami’s patent-protected technology changes that.

Timeline

  • December 2021
    Nami Surgical Founded

    Dr Nico Fenu and Dr Rebecca Cleary establish Nami Surgical as a University of Glasgow spinout, built on pioneering research from the world’s largest academic ultrasonic engineering unit.

  • June 2024
    Nami closes £3.2m seed round

    Led by Eos Advisory alongside Maven, Scottish Enterprise and SIS Ventures, the round accelerates development and commercialisation of Nami’s miniaturised ultrasonic platform

  • June 2024
    Albert Nicholl appointed chair of Nami Surgical

    Experienced MedTech executive Albert Nicholl appointed Chair of Nami Surgical, strengthening the company’s strategic and commercial leadership

  • March 2025
    David O'Reilly joins Nami's board

    David O’Reilly appointed as Corporate Strategic Advisor, bringing over 30 years of international medtech and life sciences expertise to support Nami’s commercial growth

  • September 2025
    Kevin Houser appointed IP Advisor

    Kevin Houser joins Nami as IP Champion and Advisor, bringing deep expertise in ultrasonic surgical engineering to strengthen Nami’s intellectual property strategy

  • November 2025
    First cadaver study successfully completed

    The first porcine study using Nami Surgical’s ultrasonic scalpel platform was completed. This study generates important preclinical data to support the advancement of the platform.

  • January 2026
    Nami closes a new funding round & Nikki Palfrey appointed CEO

    Nami Surgical completes £1.9m funding round and appoints Nikki Palfrey as CEO to drive commercial transition

  • February 2026
    ISO13485 certification achieved

    ISO 13485 certification achieved for the design and development of the ultrasonic scalpel platform 

  • February 2026
    First in-vivo study

    Completion of first in vivo study confirming equivalent performance to established ultrasonic surgical instruments

  • Present
    Commercial Expansion

    Nami is focused on commercial expansion, strategic partnerships and advancing the adoption of miniaturised ultrasonic technology across robotic surgery platforms.

Our Team

Leadership

  • Nikki Palfrey

    Chief Executive Officer

    Nikki is a very successful & experienced Commercial Director with a demonstrated history of working in the medical device industry. Nikki was the Chief Commercial Officer for Summit Medical and previously held a number of senior director sales and marketing roles in the surgical industry space with Orthosonics International, SRA Developments, Bowa Medical UK.

    She is highly skilled in Marketing Management, Market Planning, Sales, Medical Devices, and Business Development. Her background is a Bachelor’s degree focused in Law & Accountancy from Staffordshire University.

  • Nico Fenu PhD

    Co-Founder & Chief Operating Officer

    Nico received a BEng in Biomedical Engineering from the University of Cagliari, Italy, in 2015, and in 2017 received an MSc (Hons) in Biomedical Engineering, from the University of Dundee. He completed his PhD at the University of Glasgow on ‘Investigation of piezoelectric materials for ultrasonic surgery’ which focused on doped piezocrystals and lead-free piezoceramics for high-power, low-frequency ultrasonic applications.

    During the final year of his PhD, Dr Fenu joined the programme grant ‘Ultrasurge, Surgery enabled by Ultrasonics’ where he worked on miniaturised ultrasonic surgical tools for integration with robotics. In December 2021 Nico founded Nami Surgical Ltd. and where he serves as Nami’s Chief Operating Officer. 

  • Rebecca Cleary PhD

    Co-Founder & Chief Technical Officer

    Rebecca received an MEng in Electronic and Electrical Engineering with International Studies in 2013. She also holds a PhD from the University of Glasgow where her research focused on the use of ultrasonic needles for bone penetration.

    During this period she was rewarded with the receipt of the R.W.B Stephens prize by Elsevier at the International Conference of Ultrasonics (ICU) and Dr Alan Stirling Brown Prize for her PhD thesis.

    After 3 years as a lead post-doctorate researcher within the Centre for Medical and Industrial Ultrasonics, Dr Cleary was a key member of the cohort who founded Nami Surgical Ltd. She now leads Nami’s technical and regulatory activities as Chief Technical Officer.

Core Team

  • Alexandr Kiyashko

    Product Design Engineer

    Alexandr holds an MEng in Mechatronics Engineering from the University of Glasgow and is currently pursuing a partnership PhD, focused on advanced piezoelectric materials for high-power ultrasonic applications. During his studies, he founded a design and manufacturing start-up, gaining hands-on experience across the full product development cycle. At Nami Surgical, Alexandr works as an R&D Engineer on the development of ultrasonic scalpels, leading transducer design and materials characterisation.

  • Bartas Abaravicius PhD

    Specialist Electronics Engineer

    Bartas holds a PhD in Electronics and Electrical Engineering from the University of Glasgow in 2023, where his research focused on integrated circuits and systems for microultrasound capsule endoscopy.

    With a specialisation in analog electronics and mixed-signal system design, he brings extensive experience across the full electronics development lifecycle — from early prototyping through to testing and product finalisation.

    At Nami Surgical, Bartas works on the electronics for ultrasound transducer characterisation and drive systems. His background in ultrasound-specific circuit design allows him to bridge deep transducer knowledge with precision electronics, contributing to the development of the company’s surgical ultrasound solutions.

  • Jenny Ball

    Product Development Manager

    Jenny holds a BSc in Electronic Engineering in 2018 from South East Technological University (Ireland) and has over 8 years of expertise in medical device design, risk management and regulatory compliance. Now Product Development Manager at Nami Surgical, she is responsible for project management, early guidance on design and development, risk management activities and documentation and QMS management.

  • Jack Stevenson PhD

    Mechanical Engineering Team Leader

    Jack is a piezoelectric transducer specialist with a background in piezoelectric material characterisation and transducer design. His PhD was in designing a miniaturised HIFU transducer for robotic surgery. Some early research work includes cavitation enabled drug delivery, HIFU, LIPUS, gas coupled flow metering and next generation piezoelectric materials. Now, Jack is with Nami surgical as the mechanical team leader and working on the next generation of miniaturised ultrasonic surgical scalpels for robotic delivery.  

  • Alexandru Moldovan PhD

    Senior Specialist Systems Engineer

    Alexandru holds a Ph.D. in Electronic and Electrical Engineering from the University of Strathclyde, where he specialized in ultrasonic imaging systems, medical electronics, and advanced sensing technologies.

    He has experience spanning both industry and academic research, with a background in medical devices, robotics-assisted healthcare technologies, electronics development, software tools, and system integration for complex multidisciplinary systems.

    At Nami Surgical, Alexandru contributes to the electronic system architecture design, analog and mixed-signal circuit development, software and data acquisition tools, system integration, verification, and experimental evaluation.

  • Luke McGowan

    Workshop Manager
  • Kiara Walsh

    Innovation and Funding Associate

    Kiara holds a BSc (Hons) in Biomedical Sciences from the University of Edinburgh.  At Nami Surgical, she works across marketing, product development and funding initiatives. With a strong biological background and an interest in translating life sciences innovation into commercial success.

  • Kirsten McGlennon

    Clinical Research Associate

    Kirsten holds a BSc in Biomedical Science from the University of Strathclyde and is the Clinical Research Associate at Nami. Specialising in biological applications testing in support of Nami’s technology development, she is passionate about translating cutting-edge scientific techniques into meaningful, real-world solutions that drive innovation forward.

  • Matthew Davis

    Quality and Regulatory Affairs Manager

    Matthew has an academic background in life sciences and over 7 years of experience working in Quality across various highly regulated industries including GMP Pharmaceuticals, ISO 17025 Analytical Testing Labs and ISO 13485 Medical Devices. He is the Quality & Regulatory Affairs Manager at Nami Surgical and is responsible for maintaining and developing Nami Surgicals’ Quality Management System.

  • Rachel Stoakes PhD

    Transducer Engineer

    Rachel holds an MEng in Biomedical Engineering from the University of Glasgow and a PhD in Ultrasonic Engineering through the Centre for Doctoral Training in Future Ultrasonic Engineering (FUSE CDT) between both the University of Strathclyde and the University of Glasgow, where her doctoral research focused on advancing ultrasound technologies through acoustic metamaterials. At Nami, she supports transducer development and collaborates across engineering and biomedical teams to inform device design.

  • Mohamed Ibrahim

    Assembly Technician

    Mohamed holds a BEng (Hons) Electronic & Electrical Engineering and  a MSc in Advanced Communications from the University of Strathclyde. He has over 5 years of experience working as a technician across RF and AIT Satellites. At Nami, he applies micron-level precision skills at Nami Surgical to help assembly of ultrasonic transducers.

Board

  • Albert Nicholl

    Chairman
  • David O'Reilly MBA

    Investor Director

    David has over 25 years of experience as an entrepreneur in the life sciences industry and in the founding, financing, scaling and partnering of innovative pharmaceutical and medical technology companies.  He is currently the Managing Director of Bayview Biosciences, a firm that provides strategic advisory, product development and financing services to global life sciences companies, start-ups and investors.

    He serves on the Board of Directors of Baymatob (a women-founded and led medical technology company focused on maternal and fetal health), Neupulse (a neuromodulation company focused on wearable medical devices for Tourette Syndrome and other neurodevelopmental disorders) and Bioliberty (a soft robotics company focused on neurorehabilitation).  He is also Vice Chair and a member of the Board of Trustees for The Health Trust (a $120 million nonprofit operating foundation focused on building health equity).

    Prior to Bayview Biosciences, David held co-founder and executive roles at several other successful life sciences companies, including Proteus Digital Health, Catalyst Biosciences, Iconix Biosciences, ARIAD Pharmaceuticals and L.E.K. Consulting.  David is an inventor on over a dozen issued and pending patents related to digital and medical technologies and their application to drug discovery, therapeutic products and health care monitoring.